These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37743699)

  • 1. Sera anti-neuronal antibodies in patients with irritable bowel syndrome and their correlations with clinical profiles.
    Fan W; Fang X; Fei G; Li X; Guan H
    Neurogastroenterol Motil; 2023 Nov; 35(11):e14682. PubMed ID: 37743699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera with anti-enteric neuronal antibodies from patients with irritable bowel syndrome promote apoptosis in myenteric neurons of guinea pigs and human SH-Sy5Y cells.
    Fan W; Fei G; Li X; Wang X; Hu C; Xin H; Sun X; Li Y; Wood JD; Fang X
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13457. PubMed ID: 30230140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China.
    Lv CL; Song GQ; Liu J; Wang W; Huang YZ; Wang B; Tian JS; Yin MQ; Yu Y
    World J Gastroenterol; 2023 Nov; 29(41):5657-5667. PubMed ID: 38077156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome based on Rome IV diagnostic criteria associates with non-motor symptoms of Parkinson's disease.
    Tai YC; Liao PH; Leta V; Lin CH; Chaudhuri KR
    Parkinsonism Relat Disord; 2023 Aug; 113():105496. PubMed ID: 37385160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea.
    Zhu L; Huang D; Shi L; Liang L; Xu T; Chang M; Chen W; Wu D; Zhang F; Fang X
    Health Qual Life Outcomes; 2015 Apr; 13():49. PubMed ID: 25925746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the Enteric Nervous System to Autoimmune Diseases and Irritable Bowel Syndrome.
    Annaházi A; Schemann M
    Adv Exp Med Biol; 2022; 1383():1-8. PubMed ID: 36587141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
    Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
    Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes.
    Chen HD; Bair MJ; Chang WC; Hsu CS; Wong MW; Hung JS; Liu TT; Yi CH; Lei WY; Chen CL
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):75-80. PubMed ID: 30922615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students.
    Tan YM; Goh KL; Muhidayah R; Ooi CL; Salem O
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1412-6. PubMed ID: 14675271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in Japan.
    Otani K; Watanabe T; Takahashi K; Nadatani Y; Ominami M; Fukunaga S; Hosomi S; Kamata N; Tanaka F; Nagami Y; Taira K; Kimura T; Fukumoto S; Fujiwara Y
    BMC Gastroenterol; 2023 May; 23(1):140. PubMed ID: 37138209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.
    Wong RK; Palsson OS; Turner MJ; Levy RL; Feld AD; von Korff M; Whitehead WE
    Am J Gastroenterol; 2010 Oct; 105(10):2228-34. PubMed ID: 20502449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.